Sun Pharmaceutical Industries, one of India's largest drug manufacturers, has been hit by a ransomware attack that has affected its business operations. The attack has forced the company to take containment measures, which are expected to result in reduced revenues.
The attack, which was claimed by a ransomware group, resulted in a breach of certain file systems and the theft of company and personal data. Sun Pharma took immediate action, proactively isolating its network and initiating the recovery process. However, the impact on the company's operations has been significant, and the firm will incur expenses related to the incident and its remediation.
Sun Pharma first reported the incident on March 2, stating that it had not affected the company's core systems and operations. However, the company has now revealed that it is unable to determine the full extent of the adverse effects of the incident.
The attack on Sun Pharma highlights the growing threat of cybercrime to organizations across all sectors. A study by in January revealed that healthcare was the most attacked sector in India, followed by education, research, government, and military. The study revealed that an organization in India was attacked an average of 1,866 times per week in 2022. Globally, cyberattacks increased by 38% year on year in 2022.
The incident is a reminder of the critical role that the pharmaceutical industry plays in society and the importance of robust cybersecurity measures to safeguard operations and protect sensitive data. It also highlights the need for businesses and organizations to take proactive steps to protect themselves from cyber threats.